Effect of weight reduction on concentration of plasma total homocysteine in obese Japanese men

Obesity Research and Clinical Practice

Volumn 1, Issue 3, 2007, Pages 213-221

  Okura, Tomohiro ^a   Nakata, Yoshio ^a   Ohkawara, Kazunori ^b   Numao, Shigeharu ^c   Katayama, Yasutomi ^a   Ono, Yohei ^a   Matsuo, Tomoaki ^a   Sone, Hirohito ^a,d   Tanaka, Kiyoji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WASEDA UNIVERSITY   (Japan)

^d OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Diet; Exercise training; Hyperhomocysteinemia; Obesity; Weight reduction

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN; PYRIDOXINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FROZEN SECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; INTERMETHOD COMPARISON; JAPANESE; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 34548408556     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2007.07.003     Document Type: Article

References (34)

1. Fonseca V., Guba S.C., and Fink L.M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev 20 (1999) 738-759
2. Langman L.J., Ray J.G., Evrovski J., Yeo E., and Cole D.E. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch Intern Med 160 (2000) 961-964
3. Tanne D., Haim M., Goldbourt U., Boyko V., Doolman R., Adler Y., et al. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 34 (2003) 632-636
4. Boushey C.J., Beresford S.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274 (1995) 1049-1057
5. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F.R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 (2001) 1593-1600
6. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
7. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
8. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
9. Vague J. The degree of masculine differentiation of obesities. Am J Clin Nutr 4 (1956) 20-34
10. Rasmussen L.B., Ovesen L., Bülow I., Knudsen N., Laurberg P., and Perrild H. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr 72 (2000) 1156-1163
11. Folsom A.R., Nieto F.J., McGovern P.G., Tsai M.Y., Malinow M.R., Eckfeldt J.H., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B Vitamins: the atherosclerosis risk in communities (ARIC) study. Circulation 98 (1998) 204-210
12. Randeva H.S., Lewandowski K.C., Drzewoski J., Brooke-Wavell K., O'Callaghan C., Czupryniak L., et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 4496-4501
13. The Examination Committee of Criteria for 'Obesity Disease' in Japan, and Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
14. Durand P., Fortin L.J., Lussier-Cacan S., Davignon J., and Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load-applications of a modified HPLC method. Clin Chim Acta 252 (1996) 83-93
15. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
16. Brinkman G.L. The effect of bronchitis, smoking and occupation on ventilation. Am Rev Respir Dis 87 (1963) 684-693
17. Okura T., Nakata Y., Yamabuki K., and Tanaka K. Regional body composition changes exhibit opposing effects on coronary heart disease risk factors. Arterioscler Thromb Vasc Biol 24 (2004) 923-929
18. Borg G. Perceived exertion: a note on "history" and methods. Med Sci Sports 5 (1973) 90-93
19. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12 (1992) 279-298
20. Malinow M.R., Bostom A.G., and Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99 (1999) 178-182
21. Bland J.M., and Altman D.G. Regression towards the mean. BMJ 308 (1994) 1499
22. Mennen L.I., de Courcy G.P., Guilland J.C., Ducros V., Bertrais S., Nicolas J.P., et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 76 (2002) 1279-1289
23. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274 (1995) 1526-1533
24. De Cree C., Malinow M.R., van Kranenburg G.P., Geurten P.G., Longford N.T., and Keizer H.A. Influence of exercise and menstrual cycle phase on plasma homocysteine levels in young women-a prospective study. Scand J Med Sci Sports 9 (1999) 272-278
25. Volek J.S., Gomez A.L., Love D.M., Weyers A.M., Hesslink Jr. R., Wise J.A., et al. Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition. Eur J Clin Nutr 56 (2002) 585-592
26. Solini A., Santini E., and Ferrannini E. Effect of short-term folic acid supplemetation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes 30 (2006) 1197-1202
27. Laivuori H., Kaaja R., Turpeinen U., Viinikka L., and Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 93 (1999) 489-493
28. 6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease: European COMAC Group. Circulation 97 (1998) 437-443
29. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698
30. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577. Source Information: The Writing Group (Eva Lonn, M.D., and Salim Yusuf, D.Phil., M.B., B.S., Population Health Research Institute, McMaster University, and the Department of Medicine, Division of Cardiology, Hamilton Health Sciences, Hamilton, Ont.; Malcolm J. Arnold, M.D., Department of Medicine, Division of Cardiology, University of Western Ontario, London; Patrick Sheridan, M.Sc., Janice Pogue, M.Sc., and Mary Micks, C.T.R.C., Population Health Research Institute, McMaster University, Hamilton, Ont.; Matthew J. McQueen, M.D., Ph.D., Pathology and Molecular Medicine, McMaster University, Hamilton, Ont.; Jeffrey Probstfield, M.D., University of Washington School of Medicine, Seattle; George Fodor, M.D., Ph.D., University of Ottawa Heart Institute, Ottawa; Claes Held, M.D., Ph.D., Department of Cardiology, Karolinska University Hospital, Stockholm; and Jacques Genest, Jr., M.D., Division of Cardiology, McGill University Health Center and Royal Victoria Hospital, Montreal) assumes responsibility for the overall content and integrity of the manuscript
31. Ganji V., and Kafai M.R. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 77 (2003) 826-833
32. Jacques P.F., Bostom A.G., Wilson P.W.F., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
33. de Bree A., Verschuren W.M., Blom H.J., and Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 154 (2001) 150-154
34. Kang S.S., Wong P.W.K., and Norusis M. Homocysteinemia due to folate deficiency. Metabolism 36 (1987) 458-462